Security key
29664W105
- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 27,588,882
- Share change
- +745,992
- Total reported value
- $1,107,641,121
- Put/Call ratio
- 174%
- Price per share
- $40.15
- Number of holders
- 160
- Value change
- +$27,039,632
- Number of buys
- 82
- Number of sells
- 60
Report period
Q1 2019
Institutions
160
Top holders
10
ESPR full security history
Newer quarter: Q2 2019
Previous quarter: Q4 2018
Esperion Therapeutics, Inc. SEC filings
Esperion Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29664W105
Recent filing periods:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BB BIOTECH AG |
13F
|
Company |
1.3%
|
3,392,964
|
$156,076,000 | — | 31 Dec 2018 | |
| Meditor Group Ltd |
13F
|
Company |
1%
|
2,679,835
|
$123,272,000 | — | 31 Dec 2018 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.96%
|
2,487,300
|
$114,416,000 | — | 31 Dec 2018 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.73%
|
1,879,003
|
$86,434,000 | — | 31 Dec 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.73%
|
1,878,899
|
$86,430,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.66%
|
1,698,070
|
$78,112,000 | — | 31 Dec 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
1,507,249
|
$69,333,000 | — | 31 Dec 2018 | |
| Boxer Capital, LLC |
13F
|
Company |
0.46%
|
1,200,000
|
$55,200,000 | — | 31 Dec 2018 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.38%
|
971,635
|
$44,695,000 | — | 31 Dec 2018 | |
| FMR LLC |
13F
|
Company |
0.29%
|
739,289
|
$34,007,000 | — | 31 Dec 2018 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.22%
|
562,624
|
$25,881,000 | — | 31 Dec 2018 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.18%
|
464,700
|
$21,338,000 | — | 31 Dec 2018 | |
| Aviva Holdings Ltd. |
13F
|
Company |
0.18%
|
464,649
|
$21,374,000 | — | 31 Dec 2018 | |
| Bellevue Group AG |
13F
|
Company |
0.17%
|
451,972
|
$20,791,000 | — | 31 Dec 2018 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.15%
|
385,051
|
$17,712,000 | — | 31 Dec 2018 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.14%
|
353,961
|
$16,282,000 | — | 31 Dec 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
329,337
|
$15,149,000 | — | 31 Dec 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.11%
|
296,673
|
$13,647,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
287,817
|
$13,240,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
275,410
|
$12,668,000 | — | 31 Dec 2018 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.11%
|
274,061
|
$12,607,000 | — | 31 Dec 2018 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
241,087
|
$11,090,000 | — | 31 Dec 2018 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.09%
|
240,590
|
$11,067,000 | — | 31 Dec 2018 | |
| Spark Investment Management LLC |
13F
|
Company |
0.09%
|
227,100
|
$10,446,000 | — | 31 Dec 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
203,438
|
$9,358,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
196,890
|
$9,057,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
185,442
|
$8,531,000 | — | 31 Dec 2018 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.07%
|
183,679
|
$8,449,000 | — | 31 Dec 2018 | |
| Man Group plc |
13F
|
Company |
0.06%
|
163,786
|
$7,535,000 | — | 31 Dec 2018 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
142,289
|
$6,545,000 | — | 31 Dec 2018 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
138,958
|
$6,392,000 | — | 31 Dec 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
131,973
|
$6,071,000 | — | 31 Dec 2018 | |
| NORGES BANK |
13F
|
Company |
0.05%
|
120,350
|
$5,536,000 | — | 31 Dec 2018 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.04%
|
108,200
|
$4,977,000 | — | 31 Dec 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
104,205
|
$4,794,000 | — | 31 Dec 2018 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.04%
|
100,000
|
$4,600,000 | — | 31 Dec 2018 | |
| BANK OF NOVA SCOTIA |
13F
|
Company |
0.04%
|
100,000
|
$4,600,000 | — | 31 Dec 2018 | |
| GAM Holding AG |
13F
|
Company |
0.03%
|
88,000
|
$4,048,000 | — | 31 Dec 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
82,536
|
$3,797,000 | — | 31 Dec 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
64,597
|
$2,971,000 | — | 31 Dec 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
62,945
|
$2,895,000 | — | 31 Dec 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
53,920
|
$2,480,000 | — | 31 Dec 2018 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
50,443
|
$2,320,000 | — | 31 Dec 2018 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
46,700
|
$2,148,000 | — | 31 Dec 2018 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.02%
|
43,467
|
$1,972,000 | — | 31 Dec 2018 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
42,700
|
$1,964,000 | — | 31 Dec 2018 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.02%
|
42,400
|
$1,950,000 | — | 31 Dec 2018 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.02%
|
39,928
|
$1,837,000 | — | 31 Dec 2018 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.01%
|
36,875
|
$1,696,000 | — | 31 Dec 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
35,846
|
$1,649,000 | — | 31 Dec 2018 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q1 2019
As of 31 Mar 2019,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,588,882 shares.
The largest 10 holders included
BB BIOTECH AG, Meditor Group Ltd, Pentwater Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, Partner Fund Management, L.P., STATE STREET CORP, CREDIT SUISSE AG/, BOXER CAPITAL, LLC, and WASATCH ADVISORS INC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
152
Q1 2019 holders
160
Holder diff
8
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.